Position statement from the Indian Society of Gastroenterology, Cardiological Society of India, Indian Academy of Neurology and Vascular Society of India on gastrointestinal bleeding and endoscopic procedures in patients on antiplatelet and/or anticoagulant therapy

[1]  J. Douketis,et al.  American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period , 2022, The American journal of gastroenterology.

[2]  R. Kalayarasan,et al.  Acute Upper Non-variceal and Lower Gastrointestinal Bleeding , 2022, Journal of Gastrointestinal Surgery.

[3]  B. Mégarbane,et al.  Case series of massive direct oral anticoagulant ingestion—Treatment and pharmacokinetics data , 2022, European journal of clinical investigation.

[4]  F. Radaelli,et al.  Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update , 2021, Gut.

[5]  G. Lip,et al.  Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding , 2021, JAMA Network Open.

[6]  D. Siegal,et al.  Anticoagulant‐associated gastrointestinal bleeding: Framework for decisions about whether, when and how to resume anticoagulants , 2021, Journal of thrombosis and haemostasis : JTH.

[7]  J. Samanta,et al.  Endotherapy for Nonvariceal Upper Gastrointestinal Hemorrhage , 2021, Journal of Digestive Endoscopy.

[8]  V. Calvi,et al.  Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life , 2021, TH Open.

[9]  J. Lau,et al.  Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2021 , 2021, Endoscopy.

[10]  A. Zullo,et al.  Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO). , 2020, European journal of internal medicine.

[11]  M. Søgaard,et al.  Letter by Nielsen and Søgaard Regarding Article, "Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation: An Instrumental Variable Analysis of a Nationwide Cohort". , 2020, Circulation. Cardiovascular quality and outcomes.

[12]  T. Berzin,et al.  What constitutes urgent endoscopy? A social media snapshot of gastroenterologists’ views during the COVID-19 pandemic , 2020, Endoscopy International Open.

[13]  T. Martinussen,et al.  Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation , 2020, Circulation. Cardiovascular quality and outcomes.

[14]  M. A. Khan,et al.  Emergent versus urgent ERCP in acute cholangitis: a systematic review and meta-analysis. , 2020, Gastrointestinal endoscopy.

[15]  J. Douketis,et al.  Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. , 2019, JAMA internal medicine.

[16]  J. Kim,et al.  Cold Snare Polypectomy in Patients Taking Dual Antiplatelet Therapy: A Randomized Trial of Discontinuation of Thienopyridines , 2019, Clinical and translational gastroenterology.

[17]  L. Friberg,et al.  Risk of ischemic stroke and utility of CHA2DS2‐VASc score in women and men with atrial fibrillation , 2019, Clinical cardiology.

[18]  B. Jones,et al.  Comparison of clinical prediction tools and identification of risk factors for adverse outcomes in acute lower GI bleeding. , 2019, Gastrointestinal endoscopy.

[19]  S. Ng,et al.  Risk of Postpolypectomy Bleeding With Uninterrupted Clopidogrel Therapy in an Industry-Independent, Double-Blind, Randomized Trial. , 2019, Gastroenterology.

[20]  A. Demchuk,et al.  Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors , 2019, The New England journal of medicine.

[21]  H. Sørensen,et al.  Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy: Results From a Nationwide Danish Cohort Study , 2019, Circulation.

[22]  R. Lopes,et al.  Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding , 2019, Circulation.

[23]  F. Moustafa,et al.  Management and outcome of major bleeding in patients receiving vitamin K antagonists for venous thromboembolism. , 2018, Thrombosis research.

[24]  R. Collins,et al.  Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus , 2018, The New England journal of medicine.

[25]  Suzanne G. Orchard,et al.  Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly , 2018, The New England journal of medicine.

[26]  P. Rothwell,et al.  Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial , 2018, The Lancet.

[27]  F. Chan,et al.  Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018 , 2018, Gut.

[28]  P. Morange,et al.  Direct oral anticoagulants and digestive bleeding: therapeutic management and preventive measures , 2017, Therapeutic advances in gastroenterology.

[29]  D. Witt.  What to do after the bleed: resuming anticoagulation after major bleeding. , 2016, Hematology. American Society of Hematology. Education Program.

[30]  E. Knight,et al.  Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines , 2016, Endoscopy.

[31]  J. Olesen,et al.  Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study , 2015, BMJ : British Medical Journal.

[32]  Á. Lanas,et al.  Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[33]  E. Tapper,et al.  The Risks of Thromboembolism Vs. Recurrent Gastrointestinal Bleeding after Interruption of Systemic Anticoagulation in Hospitalized Inpatients With Gastrointestinal Bleeding: A Prospective Study , 2015, The American Journal of Gastroenterology.

[34]  D. Sautereau,et al.  Endoscopic haemostasis: an overview of procedures and clinical scenarios. , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[35]  Zaid Alirhayim,et al.  Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation. , 2014, The American journal of cardiology.

[36]  Giridhar Tirucherai,et al.  Effect of Activated Charcoal on Apixaban Pharmacokinetics in Healthy Subjects , 2013, American Journal of Cardiovascular Drugs.

[37]  J. Goldstein,et al.  Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding: A Randomized, Plasma-Controlled, Phase IIIb Study , 2013, Circulation.

[38]  W. Ageno,et al.  Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. , 2012, Archives of internal medicine.

[39]  L. Køber,et al.  Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention: A Nationwide Cohort Study , 2012, Circulation.

[40]  L. Køber,et al.  Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation. , 2012, European heart journal.

[41]  Jason C. Fish,et al.  Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[42]  Xiaowu Sun,et al.  A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. , 2011, Gastrointestinal endoscopy.

[43]  Fredrik Folke,et al.  Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. , 2010, Archives of internal medicine.

[44]  V. Wong,et al.  Continuation of Low-Dose Aspirin Therapy in Peptic Ulcer Bleeding , 2010, Annals of Internal Medicine.

[45]  L. Køber,et al.  Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data , 2009, The Lancet.

[46]  J. Cheung,et al.  Acetylsalicylic acid use in patients with acute myocardial infarction and peptic ulcer bleeding. , 2009, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[47]  K. Filion,et al.  Safety of Short-Term Discontinuation of Antiplatelet Therapy in Patients With Drug-Eluting Stents , 2009, Circulation.

[48]  R. Cestari,et al.  Predictive Factors of Mortality From Nonvariceal Upper Gastrointestinal Hemorrhage: A Multicenter Study , 2008, The American Journal of Gastroenterology.

[49]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[50]  E. Hylek,et al.  Risk of thromboembolism with short-term interruption of warfarin therapy. , 2008, Archives of internal medicine.

[51]  J. Hallas,et al.  Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study , 2006, BMJ : British Medical Journal.

[52]  S. Rana,et al.  Gastrointestinal Bleeding: From Overt to Obscure , 2006, Endoscopy.

[53]  S. Guido,et al.  Drug‐induced upper gastrointestinal disorders requiring hospitalization: a five‐year study in a South Indian hospital , 2004, Pharmacoepidemiology and drug safety.

[54]  G. Guyatt,et al.  Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.

[55]  E John Orav,et al.  Early predictors of severity in acute lower intestinal tract bleeding. , 2003, Archives of internal medicine.

[56]  O. Blatchford,et al.  A risk score to predict need for treatment for uppergastrointestinal haemorrhage , 2000, The Lancet.

[57]  F. Rosendaal,et al.  Emergency Oral Anticoagulant Reversal: The Relative Efficacy of Infusions of Fresh Frozen Plasma and Clotting Factor Concentrate on Correction of the Coagulopathy , 1997, Thrombosis and Haemostasis.

[58]  T. Rockall,et al.  Variation in outcome after acute upper gastrointestinal haemorrhage , 1995, The Lancet.

[59]  R. Joynt.  Department , 1960, Neurology.

[60]  L. Laine,et al.  No Benefit From Platelet Transfusion for Gastrointestinal Bleeding in Patients Taking Antiplatelet Agents , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[61]  Gordon H. Guyatt,et al.  Evidence-Based Management of Anticoagulant Therapy Antithrombotic Therapy and Prevention of Thrombosis , 2011 .

[62]  N. Talley.  Continuation of Low-Dose Aspirin Therapy in Peptic Ulcer Bleeding: A Randomized Trial , 2010 .

[63]  R. Joshi,et al.  Gastrointentinal bleed with clopidogrel and aspirin , 2010, Indian journal of pediatrics.

[64]  B. Gersh.  Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data , 2010 .

[65]  Ron-Li Liaw,et al.  Department of , 1993 .

[66]  D. Apel,et al.  Emergency endoscopy. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.